trial · primary record
Ustekinumab
Crohn Disease
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 159 |
| Primary completion | 2028-03-15 |
| Primary endpoint | Number of Participants With Adverse Events (AEs) |
| Registry ID | NCT05092269 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:49.795Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05092269
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Ustekinumab · approval
- Ustekinumab · compound